Biodesix (BDSX) Other Non-Current Liabilities (2019 - 2026)

Biodesix (BDSX) has reported Other Non-Current Liabilities for 8 consecutive years, with $860000.0 the latest figure, recorded in Q1 2026.

• Other Non-Current Liabilities for Q1 2026 came in at $860000.0, up 24.28% year-over-year; the trailing twelve-month figure through Mar 2026 was $860000.0 (up 24.28% YoY), and the FY2025 annual result was $1.0 million, up 25.28% from the prior year.
• Other Non-Current Liabilities was $860000.0 for Q1 2026 at Biodesix, down from $1.0 million in the prior quarter.
• Over five years, Other Non-Current Liabilities peaked at $18.6 million in Q4 2022 and troughed at $60000.0 in Q3 2022.
• Average Other Non-Current Liabilities over 5 years is $3.6 million, with a median of $744000.0 recorded in 2024.
• Year-over-year, Other Non-Current Liabilities sank 99.7% in 2022 and jumped 17475.71% in 2023.
• Over 5 years, Other Non-Current Liabilities stood at $18.6 million in 2022, then plunged by 96.18% to $712000.0 in 2023, then grew by 14.47% to $815000.0 in 2024, then climbed by 25.28% to $1.0 million in 2025, then fell by 15.77% to $860000.0 in 2026.
• Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $860000.0 in Q1 2026, $1.0 million in Q4 2025, and $769000.0 in Q3 2025.